Physician

Tariq Javed, MD

According to 2025 Medicare claims, Tariq Javed, MD (NPI: 1891973806) practices internal medicine in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is TARIQ JAVED, MD INC. (NPI: 1578967717; TIN: 472065964) and primary practice location at 93291-6237. Javed is affiliated with the Adventist Health Accountable Care, LLC (ACO ID: A3873) and Aledade 91 CA MSSP Basic E (ACO ID: A5193), participating under the MSSP model.

Javed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,249 traditional Medicare patients, billed 10,085 HCPCS/CPT codes, and received $899,212 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,846 prescription claims across 724 beneficiaries totaling $1,057,173 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 271 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $266,374 to $899,212. Similarly, Part D prescription costs have moved sharply higher in recent years, from $26,541 to $1,057,173. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	529	2,638	$266,374
2016	626	3,426	$284,838
2017	696	4,201	$344,681
2018	965	5,500	$471,241
2019	1,095	6,927	$650,605
2020	1,119	6,830	$704,424
2021	1,178	6,812	$760,974
2022	1,105	7,088	$780,501
2023	1,291	7,781	$808,924
2024	1,249	10,085	$899,212

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	67	340	$26,541
2016	167	1,086	$70,294
2017	251	2,023	$177,739
2018	313	2,375	$185,242
2019	394	2,772	$233,450
2020	434	2,986	$358,600
2021	434	2,927	$328,005
2022	471	3,099	$344,039
2023	586	4,092	$776,293
2024	724	4,846	$1,057,173

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$138
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	41	$660
2022	N/R	54	$1,526
2023	N/R	68	$1,473
2024	N/R	271	$10,711

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	656	1,592	$100
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	398	693	$76
99221	Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes	338	455	$69
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	390	2,910	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	512	1,038	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	118	4,260	$272,921
Farxiga	Dapagliflozin Propanediol	125	7,533	$137,341
Sevelamer Hcl	Sevelamer Hcl	46	3,900	$107,361
Lokelma	Sodium Zirconium Cyclosilicate	103	3,791	$95,750
Xphozah	Tenapanor Hcl	24	750	$70,173

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	11	$5,929
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	47	$1,495
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	82	$1,449
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	63	$1,049
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	53	$781

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Tariq Javed, MD?

Tedicare shows public-source Medicare data for Tariq Javed, MD (NPI 1891973806), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tariq Javed, MD have ACO affiliation data?

Tariq Javed, MD is shown with ACO affiliation data for Adventist Health Accountable Care, LLC (MSSP, ACO ID A3873) and Aledade 91 CA MSSP Basic E (MSSP, ACO ID A5193).

What billing organization is linked to Tariq Javed, MD?

Tariq Javed, MD is linked to TARIQ JAVED, MD INC. (billing NPI 1578967717) in the available physician profile data.

Does Tariq Javed, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.